Infraredx Agreement with HealthTrust to Offer Intravascular Imaging Technology
By MedImaging International staff writers Posted on 02 Nov 2014 |
Image: TVC composite image (Photo courtesy of Infraredx).
Infraredx, Inc. (Burlington, MA, USA), a medical device company focused on the diagnosis and management of coronary artery disease, has entered into an agreement with HealthTrust (San Jose, CA, USA), a US group purchasing organization. Under the agreement, HealthTrust will offer the Infraredx TVC imaging system, an innovative dual-modality intravascular imaging technology, to its member network of 1,400 acute care facilities in the United States.
The TVC imaging system is used to guide percutaneous coronary interventions (PCIs) by integrating near-infrared spectroscopy (NIRS) to detect lipid-core plaques and intravascular ultrasound (IVUS) to visualize the vessel, including the structure of plaques and the level of stenosis caused by plaque accumulation. Lipid-core plaque is a fatty coronary artery plaque known to cause PCI complications, and the rupture of lipid-core plaque is associated with most heart attacks.
“We are pleased to be selected by HealthTrust to provide our innovative TVC imaging system now to more than 25% of the hospital healthcare facilities across the United States,” said Don Southard, president and chief executive officer of Infraredx. “Our contract will enable HealthTrust members access to our novel dual-modality intravascular imaging technology, which provides valuable information for physicians to make procedural and patient care decisions aimed at improving clinical outcomes and lowering healthcare costs.”
Related Links:
Infraredx
HealthTrust
The TVC imaging system is used to guide percutaneous coronary interventions (PCIs) by integrating near-infrared spectroscopy (NIRS) to detect lipid-core plaques and intravascular ultrasound (IVUS) to visualize the vessel, including the structure of plaques and the level of stenosis caused by plaque accumulation. Lipid-core plaque is a fatty coronary artery plaque known to cause PCI complications, and the rupture of lipid-core plaque is associated with most heart attacks.
“We are pleased to be selected by HealthTrust to provide our innovative TVC imaging system now to more than 25% of the hospital healthcare facilities across the United States,” said Don Southard, president and chief executive officer of Infraredx. “Our contract will enable HealthTrust members access to our novel dual-modality intravascular imaging technology, which provides valuable information for physicians to make procedural and patient care decisions aimed at improving clinical outcomes and lowering healthcare costs.”
Related Links:
Infraredx
HealthTrust
Latest Industry News News
- Hologic Acquires UK-Based Breast Surgical Guidance Company Endomagnetics Ltd.
- Bayer and Google Partner on New AI Product for Radiologists
- Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement
- IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering
- International Societies Suggest Key Considerations for AI Radiology Tools
- Samsung's X-Ray Devices to Be Powered by Lunit AI Solutions for Advanced Chest Screening
- Canon Medical and Olympus Collaborate on Endoscopic Ultrasound Systems
- GE HealthCare Acquires AI Imaging Analysis Company MIM Software
- First Ever International Criteria Lays Foundation for Improved Diagnostic Imaging of Brain Tumors
- RSNA Unveils 10 Most Cited Radiology Studies of 2023
- RSNA 2023 Technical Exhibits to Offer Innovations in AI, 3D Printing and More
- AI Medical Imaging Products to Increase Five-Fold by 2035, Finds Study
- RSNA 2023 Technical Exhibits to Highlight Latest Medical Imaging Innovations
- AI-Powered Technologies to Aid Interpretation of X-Ray and MRI Images for Improved Disease Diagnosis
- Hologic and Bayer Partner to Improve Mammography Imaging
- Global Fixed and Mobile C-Arms Market Driven by Increasing Surgical Procedures